ASH enters the second week of August with an unusual tension: short sellers are quietly unwinding a meaningful position even as the stock trades at a premium to most Street targets — and options traders are more bullish than at any point in recent memory.
The short interest story is the week's most striking feature. Bearish positioning has fallen sharply — down 17% over the past month to 11.7% of the free float, with the retreat accelerating through late July and into early August. That is still a high absolute level, but the direction of travel is clearly against the shorts. The borrow market reinforces this: availability is generous at 325%, well above the 52-week trough of 146%, and cost to borrow has eased to just 0.49% — its lowest level in over a month. Together, these signals point to shorts covering rather than adding. The ORTEX short score has drifted down from 65.1 to 62.7 over the past two weeks, confirming the gradual unwind. Availability this loose means there is no squeeze mechanics at work here; shorts are exiting on conviction, not being forced out.
Options positioning adds a sharply contrasting layer. The put/call ratio has collapsed to 0.11 — close to its 52-week low of 0.07 — and is running well below its 20-day average of 0.16. Call volume is dominating the options market by a wide margin. This is the clearest expression of bullish sentiment in the options chain over the past year, and it has arrived just after an earnings beat that sent the stock up nearly 10% on July 28–29. The stock has tacked on another 5% this week to close at $76.45, bringing the one-month move to 16%.
The Street has chased the print hard. In the days following results, analysts at Mizuho, BMO Capital, Evercore, and UBS all raised their targets. Morgan Stanley lifted its target from $58 to $78 this week while holding at Equal-Weight. JP Morgan had already moved to $75 back in July. The consensus mean target of $79.91 now sits only modestly above the current price. That is a narrowing cushion: bulls can point to UBS's $83 Buy target as the ceiling, while the cluster of Equal-Weight ratings from Morgan Stanley and Wells Fargo (target $70) suggests the sideline view is that the easy money from this move has largely been made. The PE has expanded to 18x on a trailing basis, up more than 1.2 turns over the past month, while EV/EBITDA is running near 11.2x — both multiples reflecting a stock that the market has materially re-rated since the results.
Peer performance underscores that this is a sector-wide move, not purely an Ashland story. AVNT surged 26% on the week, FUL added 10%, and PPG gained 8%. ASH's 5% advance, while solid, actually lagged several close peers — a pattern that has appeared in recent weeks and may reflect residual short positioning acting as a gentle headwind even as it unwinds.
Insider activity is worth a brief note. The CTO sold 8,526 shares on July 29 for roughly $568K — the day after the earnings pop — which is a routine post-vesting sale rather than a bearish signal, given the trade significance score of just 1. Net insider activity over the past 90 days is marginally positive at around $700K, driven by award grants rather than open-market purchases.
The next earnings event is scheduled for November 3. Between now and then, the story to track is whether short interest — still at 11.7% of the float — continues its descent toward single digits, and whether the Street's bullish post-earnings consensus holds as the valuation re-rating leaves less room for error.
See the live data behind this article on ORTEX.
Open ASH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
